- Home
- CTOR vs IH Comparison
CTOR vs IH Comparison
Compare CTOR & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- IH
- Stock Information
- Founded
- CTOR 2021
- IH 1996
- Country
- CTOR United States
- IH China
- Employees
- CTOR N/A
- IH N/A
- Industry
- CTOR
- IH Other Consumer Services
- Sector
- CTOR
- IH Real Estate
- Exchange
- CTOR NYSE
- IH Nasdaq
- Market Cap
- CTOR 89.9M
- IH 118.5M
- IPO Year
- CTOR N/A
- IH 2020
- Fundamental
- Price
- CTOR $0.75
- IH $2.51
- Analyst Decision
- CTOR Strong Buy
- IH
- Analyst Count
- CTOR 2
- IH 0
- Target Price
- CTOR $4.50
- IH N/A
- AVG Volume (30 Days)
- CTOR 50.5K
- IH 144.3K
- Earning Date
- CTOR 02-14-2025
- IH 03-25-2025
- Dividend Yield
- CTOR N/A
- IH 3.56%
- EPS Growth
- CTOR N/A
- IH N/A
- EPS
- CTOR N/A
- IH 0.28
- Revenue
- CTOR N/A
- IH $134,002,994.00
- Revenue This Year
- CTOR N/A
- IH $15.90
- Revenue Next Year
- CTOR N/A
- IH $8.64
- P/E Ratio
- CTOR N/A
- IH $8.63
- Revenue Growth
- CTOR N/A
- IH N/A
- 52 Week Low
- CTOR $0.69
- IH $1.47
- 52 Week High
- CTOR $49.00
- IH $2.48
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- IH 63.59
- Support Level
- CTOR N/A
- IH $1.92
- Resistance Level
- CTOR N/A
- IH $2.40
- Average True Range (ATR)
- CTOR 0.00
- IH 0.14
- MACD
- CTOR 0.00
- IH 0.03
- Stochastic Oscillator
- CTOR 0.00
- IH 66.89
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.